ENDOMETRIOID CARCINOMA
Clinical trials for ENDOMETRIOID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIOID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis Phase I trial tests a combination of two oral drugs, defactinib and VS-6766, in people with advanced solid tumors such as non-small cell lung cancer, low-grade serous ovarian cancer, and pancreatic cancer. The study aims to find the safest dose and evaluate how well the drug…
Matched conditions: ENDOMETRIOID CARCINOMA
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Less invasive staging for endometrial cancer put to the test
Knowledge-focused OngoingThis phase 3 trial compares a less invasive sentinel node biopsy approach to standard staging methods in 262 women with early-stage endometrial cancer at intermediate or high risk of recurrence. The goal is to see if the sentinel node policy reduces surgical complications while s…
Matched conditions: ENDOMETRIOID CARCINOMA
Phase: PHASE3 • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC